| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2754227 | Clinical Lymphoma Myeloma and Leukemia | 2016 | 7 Pages |
Abstract
Maintenance TKI therapy after transplantation is feasible and might reduce the incidence of relapses and improve outcomes after allogeneic hematopoietic stem cell transplantation for patients with high-risk Ph+ leukemia.
Related Topics
Health Sciences
Medicine and Dentistry
Anesthesiology and Pain Medicine
Authors
Zachariah DeFilipp, Amelia A. Langston, Zhengjia Chen, Chao Zhang, Martha L. Arellano, Fuad El Rassi, Christopher R. Flowers, Vamsi K. Kota, Zaid Al-Kadhimi, Rachel Veldman, Anand P. Jillella, Sagar Lonial, Edmund K. Waller, Hanna J. Khoury,